Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000850261-18-000005
Filing Date
2018-02-27
Accepted
2018-02-26 21:50:43
Documents
109
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A srne9301710-qa.htm 10-Q/A 1262542
2 EXHIBIT 31.3 srneex313.htm EX-31.3 10555
3 EXHIBIT 31.4 srneex314.htm EX-31.4 10507
4 EXHIBIT 32.2 srneex322.htm EX-32.2 13497
  Complete submission text file 0000850261-18-000005.txt   10313189

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT srne-20170930.xml EX-101.INS 1873717
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20170930.xsd EX-101.SCH 97815
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20170930_cal.xml EX-101.CAL 115631
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20170930_def.xml EX-101.DEF 666690
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20170930_lab.xml EX-101.LAB 1074410
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20170930_pre.xml EX-101.PRE 853876
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36150 | Film No.: 18642749
SIC: 8731 Services-Commercial Physical & Biological Research